64 million infected: A brief overview of ReViral and its RSV vaccine competition
Respiratory Syncytial Virus (RSV) affects millions annually, therefore attracting many large biotechs to research a…
Respiratory Syncytial Virus (RSV) affects millions annually, therefore attracting many large biotechs to research a…
Monday: A report said that the total value of crowdfunded Biotech projects from within the EU…
One more hit to Moderna Therapeutics struck by its German competitor CureVac! The Tübingen-based company just announced the opening…
CureVac, a pioneer in the field of mRNA-based technology, today announced that the company has…
mRNA based immunotherapies are no pipe dream anymore. Germany’s CureVac just presented encouraging results of…
Everybody has already heard about Boston-based Moderna Therapeutics, the most highly valued venture-backed private Biotech, but CureVac, its…
Last week, Biotech Entrepreneurs gathered in Berlin for the Charité Entrepreneurship Summit 2015. As a spectator, I'll…
A new revolutionary treatment could help cure lung cancer. It is based on mRNA instead of…